We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
-17%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.05B
AUM Growth
-$223M
Cap. Flow
+$34.7M
Cap. Flow %
3.3%
Top 10 Hldgs %
48.18%
Holding
82
New
3
Increased
31
Reduced
13
Closed
7

Top Buys

Rank Stock Value
1
TCMD icon
Tactile Systems Technology
TCMD
+$26.6M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$23.1M
3
RARE icon
Ultragenyx Pharmaceutical
RARE
+$21.2M
4
PLRX icon
Pliant Therapeutics
PLRX
+$19.5M
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$17.7M

Top Sells

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$146M
2
ABCM
Abcam PLC
ABCM
+$17.4M
3
KRYS icon
Krystal Biotech
KRYS
+$11.9M
4
HALO icon
Halozyme
HALO
+$11.1M
5
OFIX icon
Orthofix Medical
OFIX
+$10.9M

Sector Composition

Rank Sector Weight
1 Healthcare 95.63%
2 Communication Services 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
26
Insmed
INSM
$21.4B
$16.3M 1.54%
643,588
-2,098
-0.3% -$48K
KRMD icon
27
KORU Medical Systems
KRMD
$189M
$14.3M 1.36%
5,287,296
-12,343
-0.2% -$33.8K
ANAB icon
28
AnaptysBio
ANAB
$1.58B
$14.2M 1.35%
790,806
+468,598
+145% +$8.94M
OMCL icon
29
Omnicell
OMCL
$1.61B
$13.9M 1.32%
309,244
-12,420
-4% -$752K
KROS icon
30
Keros Therapeutics
KROS
$199M
$13.4M 1.28%
421,438
+4,608
+1% +$172K
HALO icon
31
Halozyme
HALO
$9.79B
$12M 1.14%
313,536
-270,712
-46% -$11.1M
OM icon
32
Outset Medical
OM
$84.7M
$11.1M 1.06%
68,088
+25,593
+60% +$6.04M
KIDS icon
33
OrthoPediatrics
KIDS
$519M
$9.77M 0.93%
305,238
+6,262
+2% +$241K
AXGN icon
34
Axogen
AXGN
$2.27B
$9.63M 0.91%
1,925,132
-48,567
-2% -$336K
SCTL
35
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$9.23M 0.88%
19,676,396
+6,271,366
+47% +$4.48M
IRTC icon
36
iRhythm Holdings
IRTC
$3.85B
$8.3M 0.79%
+88,039
New +$8.95M
GH icon
37
Guardant Health
GH
$21.5B
$5.89M 0.56%
198,783
+1,079
+0.5% +$37.9K
GMAB icon
38
Genmab
GMAB
$17.7B
$5.54M 0.53%
157,147
-1,362
-0.9% -$51.9K
BMRN icon
39
BioMarin Pharmaceuticals
BMRN
$11.6B
$5.46M 0.52%
61,756
+1,102
+2% +$98.1K
MXCT icon
40
MaxCyte
MXCT
$112M
$3.35M 0.32%
1,073,110
-784,456
-42% -$3.15M
SONX
41
DELISTED
Sonendo, Inc.
SONX
$3.12M 0.3%
4,185,619
– –
MIRO
42
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$2.99M 0.28%
2,278,670
+52,930
+2% +$77.2K
TECH icon
43
Bio-Techne
TECH
$11.2B
$2.24M 0.21%
32,889
-289
-0.9% -$22.8K
OKUR
44
OnKure Therapeutics
OKUR
$154M
$2.07M 0.2%
27,232
+2,232
+9% +$152K
SLP icon
45
Simulations Plus
SLP
$369M
$1.46M 0.14%
35,057
-298
-0.8% -$13.5K
CUTR
46
DELISTED
Cutera, Inc.
CUTR
$1.45M 0.14%
240,078
-330,651
-58% -$4.19M
HUM icon
47
Humana
HUM
$43.7B
$432K 0.04%
888
– –
NVS icon
48
Novartis
NVS
$297B
$420K 0.04%
4,123
– –
FMS icon
49
Fresenius Medical Care
FMS
$13.8B
$420K 0.04%
19,490
– –
SNY icon
50
Sanofi
SNY
$103B
$414K 0.04%
7,711
– –
1
2
3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, First Light Asset Management held 82 positions worth $1.05B, down 17% from $1.28B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

First Light Asset Management deployed $34.7M of net new capital in Q3 2023, opening 3 new positions and adding to 31 existing holdings. Its largest new stake was Structure Therapeutics: 374,412 shares worth $18.9M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Communication Services.

On the sell side, the largest reduction was Halozyme, an estimated $11.1M trimmed.

  • First Light Asset Management's largest Q3 2023 buy was Structure Therapeutics: 374,412 shares worth $18.9M.
  • First Light Asset Management added most to Tactile Systems Technology in Q3 2023, an estimated $26.6M increase.
  • First Light Asset Management's biggest Q3 2023 reduction was Halozyme, cutting an estimated $11.1M.
  • First Light Asset Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $146M.
  • First Light Asset Management's ten largest holdings make up 48% of its $1.05B portfolio in Q3 2023.
  • First Light Asset Management opened 3 new positions and closed 7 in Q3 2023.
  • First Light Asset Management's portfolio value fell 17% quarter-over-quarter to $1.05B.

Based on First Light Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.